{"id":68758,"date":"2026-02-21T13:56:34","date_gmt":"2026-02-21T13:56:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68758"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"tb-500","status":"publish","type":"product","link":"https:\/\/medsbase.com\/fr\/product\/tb-500\/","title":{"rendered":"TB-500 (Thymosine B\u00eata-4)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">R\u00e9ponse rapide \u2014 Qu'est-ce que TB-500 ?<\/h3>\n<p style=\"margin: 0;\"><strong>TB-500<\/strong> est un analogue synth\u00e9tique de <strong>Thymosine B\u00eata-4<\/strong>, a naturally occurring 43-amino-acid peptide with systemic healing activity. In published preclinical studies it binds G-actin, stimulates angiogenesis via the VEGF\/KDR pathway, and modulates TGF-beta inflammatory signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Ce que vous obtenez avec MedsBase :<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/fr\/reviews\/\">avis clients<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Chaque commande est couverte par notre <a href=\"https:\/\/medsbase.com\/fr\/medsbase-re-shipment-assurance-policy\/\"><strong>Politique de R\u00e9exp\u00e9ditions Garanties<\/strong><\/a> \u2014 si votre colis n'arrive pas dans les 20 jours ouvrables, nous le r\u00e9exp\u00e9dions.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Sp\u00e9cification<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">D\u00e9tail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Num\u00e9ro CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">77591-33-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formule mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Masse mol\u00e9culaire<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~4963 Da (N-ac\u00e9tyl Thymosine \u03b2-4 (1\u201343))<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>S\u00e9quence<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forme<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Poudre lyophilis\u00e9e (ou tel que fourni)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Puret\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599 % (v\u00e9rifi\u00e9 par HPLC, COA sur demande)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Stockage<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Lyophilis\u00e9 : 2\u20138\u00a0\u00b0C (r\u00e9frig\u00e9rateur) pour le stock de travail ; \u221220\u00a0\u00b0C pour le stockage \u00e0 long terme des flacons non ouverts. Reconstitu\u00e9 : 2\u20138\u00a0\u00b0C, utiliser dans les ~30 jours. \u00c9vitez une agitation vigoureuse ; les gros peptides se d\u00e9naturent avec le secouage. Ne pas congeler-d\u00e9congeler la solution reconstitu\u00e9e.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e9<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Eau bact\u00e9riostatique (recommand\u00e9e) ou eau st\u00e9rile pour des fen\u00eatres d'utilisation plus courtes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Qu'est-ce que TB-500 ?<\/h2>\n<p><strong>TB-500<\/strong> is the clinical designation for a synthetic analog of <strong>Thymosine B\u00eata-4 (TB4)<\/strong>, a naturally-occurring 43-amino-acid peptide hormone found in nearly every cell of the human body. TB4 is most abundant in platelets, and is released at sites of tissue damage where it orchestrates cell migration, angiogenesis, and anti-inflammatory signaling. The synthetic form \u2014 TB-500 \u2014 reproduces the biological activity of TB4 and is the most widely studied compound in this class. The TB4 sequence is <em>Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/em>, molecular weight approximately 4,963\u00a0Da. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, published trial detail, and dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/fr\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 guide<\/a>. <\/p>\n<h2>M\u00e9canisme d'action \u2014 Cicatrisation syst\u00e9mique via trois voies<\/h2>\n<p>Le TB-500 se distingue de la plupart des peptides par sa <strong>distribution syst\u00e9mique et sa longue demi-vie circulante<\/strong>, which allow a single administration to influence repair processes across multiple tissues simultaneously. The three primary mechanistic pathways in published studies:<\/p>\n<ul>\n<li><strong>S\u00e9questration de la G-actine<\/strong> \u2014 TB-500 binds monomeric actin (G-actin) via a central actin-binding motif (LKKTETQ). This preserves the cytoskeletal reservoir cells need to extend pseudopodia, migrate toward injury sites, and remodel after damage. Cell-migration assays in wound-edge studies consistently show enhanced migration rates in TB4-treated cells.<\/li>\n<li><strong>Angiogen\u00e8se via la signalisation VEGF\/KDR<\/strong> \u2014 TB-500 stimulates vascular endothelial migration and capillary formation through the VEGF receptor 2 (KDR) pathway. In ischemia-reperfusion and wound-healing studies this translates to faster restoration of perfusion at repair sites.<\/li>\n<li><strong>Signalisation anti-inflammatoire via la modulation du TGF-b\u00eata<\/strong> \u2014 TB-500 reduces pro-inflammatory cytokine release and accelerates resolution of the inflammatory phase of healing. In cardiac ischemia studies, this has been linked to reduced infarct size and preserved cardiomyocyte function.<\/li>\n<\/ul>\n<p>Comme ces trois m\u00e9canismes se distribuent dans tout l'organisme, le TB-500 produit des effets dans des tissus \u00e9loign\u00e9s du site d'injection \u2014 la caract\u00e9ristique qui le distingue des peptides de cicatrisation plus localis\u00e9s tels que <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a>. The practical consequence: TB-500 protocols are dosed twice weekly rather than daily. <\/p>\n<h2>Published Evidence<\/h2>\n<p>TB-500 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>R\u00e9paration des muscles squelettiques<\/strong> \u2014 cin\u00e9tique de r\u00e9cup\u00e9ration syst\u00e9mique dans les mod\u00e8les rongeurs de l\u00e9sions par \u00e9crasement, de tension et d'atrophie par d\u00e9sutilisation<\/li>\n<li><strong>Cardiac recovery<\/strong> \u2014 survie des cardiomyocytes, taille de l'infarctus et remodelage vasculaire post-isch\u00e9mie (Smart et al., Nature 2011 ; Bock-Marquette et al., Nature 2004)<\/li>\n<li><strong>Cicatrisation des tendons et ligaments<\/strong> \u2014 seul ou en combinaison avec <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> in connective-tissue repair studies<\/li>\n<li><strong>R\u00e9paration syst\u00e9mique des plaies<\/strong> \u2014 dermal and corneal wound-healing studies, especially where multiple tissue beds are affected<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 follicular angiogenesis and hair-growth phase transitions in rodent study models<\/li>\n<li><strong>R\u00e9paration vasculaire<\/strong> \u2014 endothelial cell migration, capillary formation, and ischemia studies<\/li>\n<li><strong>Comparative peptide studies<\/strong> \u2014 \u00e9valuation par rapport au BPC-157 en tant que comparateur canonique de la cicatrisation locale, ou avec <a href=\"https:\/\/medsbase.com\/fr\/igf-1-lr3-peptide-guide\/\">IGF-1 LR3<\/a> et <a href=\"https:\/\/medsbase.com\/fr\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin\/CJC-1295<\/a> in growth-factor studies. See our <a href=\"https:\/\/medsbase.com\/fr\/bpc-157-vs-tb-500-comparison-guide\/\">comparaison BPC-157 vs TB-500<\/a> pour une comparaison c\u00f4te \u00e0 c\u00f4te.<\/li>\n<\/ul>\n<p>Pour un contexte plus large sur la place du TB-500 dans le paysage des peptides de cicatrisation, voir <a href=\"https:\/\/medsbase.com\/fr\/best-peptides-for-muscle-recovery\/\">les meilleurs peptides pour la r\u00e9cup\u00e9ration musculaire<\/a> cluster article and complementary compounds in the <a href=\"https:\/\/medsbase.com\/fr\/peptides\/\">catalogue de peptides<\/a>. <\/p>\n<h2>Forces et concentrations disponibles<\/h2>\n<p>MedsBase propose le TB-500 (Thymosine B\u00eata-4 synth\u00e9tique) dans les formats de flacons lyophilis\u00e9s suivants. Chaque variante est disponible en packs de 10, 20 ou 30 flacons avec des instructions compl\u00e8tes de reconstitution :<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Concentration du flacon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Cas d'utilisation typique<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tailles de conditionnement<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot studies, titration, or short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, matches common 2\u20132.5\u00a0mg dose-per-administration protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended studies, bulk prep, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 flacons<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials offer lower per-mg cost and are generally preferred when users are modeling the 2\u20132.5\u00a0mg per-administration dose used across most published TB-500 protocols. <\/p>\n<h2>Comparaison \u2014 TB-500 vs BPC-157<\/h2>\n<p>Le TB-500 et <a href=\"https:\/\/medsbase.com\/fr\/bpc-157\/\">BPC-157<\/a> are the two most-cited healing peptides. They are often studied together because their mechanisms are complementary rather than overlapping \u2014 BPC-157 acts locally via growth-factor upregulation, TB-500 acts systemically via actin and angiogenesis pathways. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e8re<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Thymosine B\u00eata-4)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longueur<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 acides amin\u00e9s (~4 963 Da)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 acides amin\u00e9s (~1 419 Da)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>M\u00e9canisme principal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">S\u00e9questration de la G-actine, angiogen\u00e8se, TGF-b\u00eata<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + r\u00e9gulation positive des r\u00e9cepteurs GH<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribution<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Syst\u00e9mique, se distribue largement<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Plus localis\u00e9e au site d'injection<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dose typique<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg deux fois par semaine, phase de charge de 4\u20136 semaines<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132 fois par jour<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiaque, musculaire syst\u00e9mique, vasculaire, pileux<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tendon, ligament, barri\u00e8re intestinale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Empilement<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Souvent co-administr\u00e9 avec le BPC-157<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Souvent co-administr\u00e9 avec le TB-500<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For the full side-by-side methodological comparison and when users pick one over the other, read <a href=\"https:\/\/medsbase.com\/fr\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500 : quel peptide de gu\u00e9rison pour votre objectif de r\u00e9cup\u00e9ration<\/a>. <\/p>\n<h2>Stockage et reconstitution<\/h2>\n<p><strong>Avant la reconstitution :<\/strong> conserver les flacons lyophilis\u00e9s au r\u00e9frig\u00e9rateur entre 2 et 8 \u00b0C dans leur emballage d'origine. Le TB-500 lyophilis\u00e9 est stable dans ces conditions jusqu'\u00e0 36 mois. \u00c9vitez les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation de la poudre. <strong>Proc\u00e9dure de reconstitution :<\/strong> injecter de l'eau bact\u00e9riostatique le long de la paroi lat\u00e9rale du flacon de peptide (pas directement sur le g\u00e2teau lyophilis\u00e9) selon le tableau de dilution ci-dessus. Tourner doucement \u2014 ne pas <strong>re\u00e7oit pas<\/strong> agiter \u2014 et laisser 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Une solution correctement reconstitu\u00e9e doit \u00eatre claire et incolore. <strong>Apr\u00e8s reconstitution :<\/strong> conserver au r\u00e9frig\u00e9rateur \u00e0 2\u20138 \u00b0C et utiliser dans les 30 jours pour une stabilit\u00e9 optimale. Ne pas congeler la solution reconstitu\u00e9e \u2014 les cycles de cong\u00e9lation-d\u00e9cong\u00e9lation d\u00e9gradent l'int\u00e9grit\u00e9 du peptide. Jeter tout flacon pr\u00e9sentant de la turbidit\u00e9, un pr\u00e9cipit\u00e9 ou une d\u00e9coloration. <\/p>\n<h2 id=\"faqs\">Questions fr\u00e9quemment pos\u00e9es<\/h2>\n<h3>What is TB-500 used for in studies?<\/h3>\n<p>TB-500 is used in studies investigating skeletal muscle repair, cardiac recovery, tendon and ligament healing, wound repair, hair-cycle studies, vascular repair, and systemic tissue regeneration. It is <strong>re\u00e7oit pas<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>En quoi le TB-500 diff\u00e8re-t-il du BPC-157 ?<\/h3>\n<p>TB-500 is a 43-amino-acid synthetic analog of Thymosin Beta-4 that acts systemically via G-actin binding, angiogenesis, and TGF-beta signaling. BPC-157 is a 15-amino-acid pentadecapeptide that acts mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. The two are often co-administered in studies because their mechanisms are complementary. <\/p>\n<h3>What is the typical TB-500 dose?<\/h3>\n<p>Les protocoles pr\u00e9cliniques publi\u00e9s utilisent g\u00e9n\u00e9ralement 2\u20132,5 mg par administration, administr\u00e9s deux fois par semaine pendant une phase de charge de 4\u20136 semaines, suivie d'une phase d'entretien hebdomadaire. Un flacon de 5 mg reconstitu\u00e9 avec 2,0 mL d'eau bact\u00e9riostatique donne une concentration de 2,5 mg\/mL \u2014 80 crans sur une seringue U-100 d\u00e9livrent 2 mg. <\/p>\n<h3>Le TB-500 est-il approuv\u00e9 par la FDA ?<\/h3>\n<p>No. TB-500 (synthetic Thymosin Beta-4) is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>Comment le TB-500 doit-il \u00eatre stock\u00e9 ?<\/h3>\n<p>Flacons lyophilis\u00e9s : r\u00e9frig\u00e9r\u00e9s \u00e0 2\u20138 \u00b0C dans leur emballage d'origine, stables jusqu'\u00e0 36 mois. Solution reconstitu\u00e9e : r\u00e9frig\u00e9r\u00e9e \u00e0 2\u20138 \u00b0C, \u00e0 utiliser dans les 30 jours. Ne pas congeler la solution reconstitu\u00e9e \u2014 les cycles de gel-d\u00e9gradation alt\u00e8rent le peptide. <\/p>\n<h3>Comment reconstituer le TB-500 ?<\/h3>\n<p>Suivez le tableau de r\u00e9f\u00e9rence de reconstitution ci-dessus. Ajoutez de l'eau bact\u00e9riostatique le long de la paroi du flacon (pas directement sur la poudre lyophilis\u00e9e), agitez doucement et laissez reposer 5 \u00e0 10 minutes pour une dissolution compl\u00e8te. Ne <strong>re\u00e7oit pas<\/strong> secouez pas le flacon. <\/p>\n<h3>Quelles sont les dosages disponibles chez MedsBase ?<\/h3>\n<p>MedsBase propose du TB-500 en flacons lyophilis\u00e9s de 2 mg, 5 mg et 10 mg. Chaque dosage est disponible en packs de 10, 20 ou 30 flacons. Tous les flacons sont fournis avec une puret\u00e9 HPLC de 99 %+ et un certificat d'analyse disponible sur demande. <\/p>\n<h3>Can TB-500 and BPC-157 be stacked in studies?<\/h3>\n<p>Yes. TB-500 and BPC-157 are among the most commonly co-administered peptides in preclinical studies. Their mechanisms are complementary (systemic vs local, actin-binding vs growth-factor-upregulation), and combined protocols appear frequently in connective-tissue and muscle recovery. See our <a href=\"https:\/\/medsbase.com\/fr\/bpc-157-vs-tb-500-comparison-guide\/\">guide comparatif<\/a>. <\/p>\n<h3>Pourquoi le TB-500 est-il dos\u00e9 moins souvent que le BPC-157 ?<\/h3>\n<p>TB-500 has a longer circulating half-life and distributes systemically, so published studies protocols typically dose twice weekly. BPC-157 is more localized and commonly dosed once or twice daily in the same types of injury-model studies. <\/p>\n<h3>Does TB-500 cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a reasonable safety profile at typical doses. Published toxicology work has not identified off-target signals at standard doses. <\/p>\n<h3>Le TB-500 est-il identique \u00e0 la Thymosine B\u00eata-4 compl\u00e8te ?<\/h3>\n<p>TB-500 is marketed as a synthetic form of Thymosin Beta-4 (TB4). In commercial supply, what is sold as &#8220;TB-500&#8221; is typically the full 43-amino-acid TB4 molecule synthesized chemically. Some literature refers to shorter actin-binding fragments (LKKTETQ) as functional TB4 analogs in narrow contexts, but full-length TB4 is the dominant form. <\/p>\n<h3>Quelle est la demi-vie du TB-500 ?<\/h3>\n<p>TB-500 (synthetic Thymosin Beta-4) has an estimated serum half-life of several days in preclinical studies \u2014 significantly longer than most GHRPs and site-specific healing peptides such as BPC-157. This extended half-life supports the less-frequent dosing schedules typically used in T\u03b24 protocols. <\/p>\n<h3>How long does TB-500 take to show effects in preclinical studies?<\/h3>\n<p>Preclinical studies using Thymosin Beta-4 in cardiac, skeletal muscle, and connective tissue models typically observe measurable effects over 2\u20134 week cycles. The systemic distribution and longer half-life compared to site-directed peptides mean TB-500 timelines are generally extended. <\/p>\n<h3>Puis-je commander du TB-500 pour une livraison internationale ?<\/h3>\n<p>Oui. MedsBase exp\u00e9die le TB-500 dans le monde entier depuis notre r\u00e9seau d\u00e9di\u00e9 \u00e0 l'exp\u00e9dition de peptides. Les commandes contenant uniquement des peptides sont \u00e9ligibles \u00e0 notre service d'exp\u00e9dition d\u00e9di\u00e9. Toutes les commandes sont exp\u00e9di\u00e9es dans un emballage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e avec un suivi complet. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">Le TB-500 est souvent utilis\u00e9 conjointement avec le BPC-157 \u2014 l'angiogen\u00e8se (BPC-157) associ\u00e9e \u00e0 la r\u00e9paration du cytosquelette (TB-500) permet une r\u00e9cup\u00e9ration des tissus mous plus rapide et plus compl\u00e8te qu'avec un seul peptide ; notre <a href=\"\/fr\/peptide-healing-stack\/\">Stack de gu\u00e9rison par peptides (BPC-157 5 mg + TB-500 5 mg + eau bact\u00e9riostatique)<\/a> exp\u00e9die le protocole combin\u00e9 en un seul colis.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/fr\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/fr\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 Agoniste s\u00e9lectif de la ghr\u00e9line \u2014 pic d'hormone de croissance propre sans cortisol\/prolactine<\/li>\n<li><a href=\"\/fr\/cjc-1295-with-dac\/\"><strong>CJC-1295 avec DAC<\/strong><\/a> \u2014 Analogue de GHRH avec demi-vie prolong\u00e9e<\/li>\n<li><a href=\"\/fr\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/fr\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Pour en savoir plus<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lisez notre guide complet bas\u00e9 sur des preuves : <a href=\"https:\/\/medsbase.com\/fr\/tb-500-thymosin-beta-4-peptide-guide\/\"><strong>TB-500 \u2014 m\u00e9canisme, donn\u00e9es d'essais et perspectives<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorise la r\u00e9g\u00e9n\u00e9ration cellulaire<br \/>\n\u2705 Am\u00e9liore la mod\u00e9lisation tissulaire<br \/>\n\u2705 Stimule l'activit\u00e9 des fibroblastes<br \/>\n\u2705 Active la signalisation angiog\u00e9nique<br \/>\n\u2705 Am\u00e9liore la stabilit\u00e9 de la matrice extracellulaire<\/p>\n<p><strong>TB-500<\/strong> contient un compos\u00e9 peptidique synth\u00e9tique.<\/p>","protected":false},"featured_media":70987,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,5442,5443],"class_list":["post-68758","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-tb-500","product_tag-thymosin-beta-4","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product\/68758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/comments?post=68758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media\/70987"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/media?parent=68758"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_brand?post=68758"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_cat?post=68758"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/fr\/wp-json\/wp\/v2\/product_tag?post=68758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}